Assessment of association of serum lactate level with retinopathy of prematurity

No Thumbnail Available

Date

2021

Journal Title

Journal ISSN

Volume Title

Publisher

Gazi Eye Foundation

Open Access Color

OpenAIRE Downloads

OpenAIRE Views

Research Projects

Organizational Units

Journal Issue

Abstract

Purpose: To assess the relation between serum lactate level and development and progression of retinopathy of prematurity (ROP). Material and Methods: This retrospective study included premature newborns that received intensive medical care. Serum lactate levels that were obtained with three-day intervals during the fi rst month after birth was noted. Patients with ROP were included in ROP group and patients without ROP were included in control group. Results: 71 patients were included in ROP group and 35 patients included in control group. Mean gestational age 27.8 ± 1.8 weeks in ROP group and 28.7 ± 3.2 weeks in control group (p=0.061). Mean birth weight was 1150.4 ± 251.7 and 1262.3 ± 323.9 grams in ROP and control groups respectively (p<0.078). Mean serum lactate level at the fi rst day after birth was 36.6 ± 22.3 mg/dl in ROP group and 24.9 ± 12.8 mg/dl in control group (p<0.001). Mean serum lactate level at the fi rst month after birth was 26.6 ± 7.9 mg/dl in ROP group and 18.1 ± 6.5 mg/dl in control group (p<0.001). No signifi cant relation was observed between lactate level at the fi rst day and month and ROP stage and plus disease (p>0.05). Mean serum lactate level equal or over 21.2 mg/dl at the fi rst month predicted the development of ROP with a 76% sensitivity and 74% specifi city (Area under the curve: 0.837, p<0.001). Conclusion: Higher serum lactate levels were found associated with ROP and serum lactate level could be used to predict the development of ROP. © 2021 Gazi Eye Foundation. All rights reserved.

Description

Keywords

Lactate, Retinopathy of prematurity, Vascular endothelial growth factor

Turkish CoHE Thesis Center URL

Fields of Science

Citation

0

WoS Q

Scopus Q

Q4

Source

Retina-Vitreus

Volume

30

Issue

1

Start Page

9

End Page

12